Herbrink, P.

patient antibody campylobacter infection carcinoma elisa cancer control study reactivity lymph anti-galc gbs patients antigen disease detection lymph nodes primer 7\6-35 polymerase chain reaction group stage papillomaviru department netherland presence jejuni anti-galc antibodies result serum hpv dna sensitivity anti-e syndrome assay guillain value peptide anti-galc reactivity lesion hpv -16 dna tumour table primers enteriti reaction lesion size polymerase rea patients lymph node involvement anti-e 7 positivity prevalence pretreatment sera positivity campylobacter infection -16 response chain analysis sample peptide e 7\6-35 primer pairs campylobacter enteritis campylobacter jejuni cancer patients plate method figo stages prognostic value ts primers igm antibodies prevalence rate microbiology barre anti-e 7\6-35 positivity culture grade lymph node metastases ts primer pairs pretreatment